Rob Bryant
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Robert Bryant completed his undergraduate medical degree at the University of Adelaide in 2005 and was awarded Fellowship of the Royal Australasian College of Physicians in 2013, specialising in Gastroenterology. Thereafter, he undertook a Clinical Fellowship in Inflammatory Bowel Diseases under the supervision of Professor Simon Travis at the John Radcliffe Hospital Oxford (2013-2014). He subsequently completed a Master of Science by Research (MScR) at the University of Oxford in the field of genetics and mucosal immunology in inflammatory bowel diseases (2014-2015). Dr Bryant is currently a PhD candidate at the University of Adelaide and works as a Consultant Gastroenterologist within the IBD Service at the Royal Adelaide Hospital.
Dr Bryant is actively involved in research in the field of inflammatory bowel diseases (IBD). He is interested in the influence on diet and the gut microbiome on disease pathogenesis and outcomes in IBD. He is also exploring treatment targets and disease activity assessment in IBD, with an overall goal of improving outcomes for this patient cohort.
-
Expand
-
Appointments
Date Position Institution name 2018 Clinical Senior Lecturer University of Adelaide 2017 Staff Specialist Gastroenterologist, Head of Inflammatory Bowel Diseases Queen Elizabeth Hospital 2016 Basic Physician Training Clinical tutor and examiner Queen Elizabeth Hospital 2016 Clinical Lecturer, Medical School Lecture Series University of Adelaide 2016 - 2016 Gastrointestinal Ultrasound Fellowship Sacco University Hospital 2015 - 2018 Lecturer SAPMEA Postgraduate Medical Education Association lectures 2015 - 2017 Consultant Gastroenterologist Royal Adelaide Hospital 2015 Visiting Medical Specialist Alice Springs Hospital 2014 - 2015 Clinical Research Fellow University of Oxford 2013 - 2015 Senior Clinical Fellow in Gastroenterology John Radcliffe Hospital 2011 - 2013 Gastroenterology Advanced Trainee Royal Adelaide Hospital 2011 - 2012 Academic and clinical tutor, Basic Physician Training Program Royal Adelaide Hospital 2011 - 2012 Guest lecturer and bedside tutor University of Adelaide 2008 - 2011 Basic Physician Trainee Royal Adelaide Hospital 2007 - 2007 Resident Medical Officer Royal Hobart Hospital 2006 - 2006 Internship Royal Perth Hospital -
Awards and Achievements
Date Type Title Institution Name Country Amount 2016 Scholarship AR Clarkson Scholarship Royal Adelaide Hospital Research Committee Australia — 2012 Award Mark Jolly Foundation Fellowship Award Royal Adelaide Hospital Australia — 2012 Award Professor Derek Frewin Clinical Teaching Award School of Medicine, University of Adelaide Australia — 2010 Award Professor Derek Frewin Clinical Teaching Award School of Medicine, University of Adelaide Australia — 2004 Award Meritous award for Geriatrics School of Medicine, University of Adelaide Azerbaijan — 2004 Award Meritous Award for Obstetrics and Gynaecology School of Medicine, University of Adelaide Australia — -
Education
Date Institution name Country Title 2015 University of Adelaide Australia PhD Candidate 2014 - 2015 University of Oxford United Kingdom Master of Science (by Research) MScR 2005 University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery (MBBS) -
Postgraduate Training
Date Title Institution Country 2014 - 2015 Master of Science by Research (MScR) University of Oxford United Kingdom 2011 - 2013 Fellowship of the Royal Australasian College of Physicians (FRACP) Royal Australasian College of Physicians Australia -
Research Interests
-
Expand
-
Journals
Year Citation 2021 Goodsall, T. M., Nguyen, T. M., Parker, C. E., Ma, C., Andrews, J. M., Jairath, V., & Bryant, R. V. (2021). Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.. J Crohns Colitis, 15(1), 125-142.
Scopus32021 Day, A. S., Wood, J. A., Halmos, E. P., & Bryant, R. V. (2021). Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. Journal of the Academy of Nutrition and Dietetics, 121(2), 201-209.
2021 Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3.
2021 Ma, C., Sedano, R., Almradi, A., Casteele, N. V., Parker, C. E., Guizzetti, L., . . . Jairath, V. (2021). An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.. Gastroenterology.
2021 Goodsall, T. M., Jairath, V., Feagan, B. G., Parker, C. E., Nguyen, T. M., Guizzetti, L., . . . Ma, C. (2021). Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Alimentary Pharmacology and Therapeutics, 53(8), 873-886.
Scopus2 WoS22021 Soo, W. T., Costello, S. P., & Bryant, R. V. (2021). Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 3 pages.
2021 Goodsall, T. M., Jairath, V., Bryant, R. V., & Ma, C. (2021). Editorial: use of intestinal ultrasound in the scoring of Crohn’s disease activity in clinical trials – is it ready for prime time yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 53(8), 948-949.
2020 Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2020). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study. Journal of Human Nutrition and Dietetics, 34(2), 420-428.
Scopus2 WoS1 Europe PMC12020 Meyer, E. J., Mignone, E., Hade, A., Thiruvenkatarajan, V., Bryant, R. V., & Jesudason, D. (2020). Periprocedural euglycemic diabetic ketoacidosis associated with sodium– glucose cotransporter 2 inhibitor therapy during colonoscopy. Diabetes Care, 43(11), e181-e184.
Scopus1 WoS12020 Goodsall, T. M., Han, S., & Bryant, R. V. (2020). Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. Journal of Gastroenterology and Hepatology (Australia), 6 pages.
2020 Schubert, J. P., Gehlert, J., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., Mangoni, A. A., & Bryant, R. V. (2020). Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis.. Journal of gastroenterology and hepatology, 7 pages.
2020 Aysha, A. A., Rentsch, C., Prentice, R., Johnson, D., Bryant, R. V., Ward, M. G., . . . Christensen, B. (2020). Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Internal Medicine Journal, 50(7), 798-804.
Scopus2 WoS2 Europe PMC12020 Vanlint, A. S., Kaazan, P., Kwok, M., Bryant, R. V., Ooi, M., Bak, N., & Costello, S. (2020). Lessons from practice Low attenuation lymphadenopathy on computed tomography leading to diagnosis of Whipple disease. Medical Journal of Australia, 213(4), 161-162.e1.
2020 Gill, M., Blacketer, C., Chitti, F., Telfer, K., Papanicolas, L., Dann, L. M., . . . Costello, S. P. (2020). Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. JGH Open, 4(5), 950-957.
2020 Costello, S. P., Day, A., Yao, C. K., & Bryant, R. V. (2020). Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis. BMJ Case Reports, 13(8), e233135.
2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough. Journal of Crohn's and Colitis, 14(10), 1341-1342.
Europe PMC12020 Day, A., Wood, J., Melton, S., & Bryant, R. V. (2020). Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease. JGH Open, 4(2), 260-266.
Scopus3 Europe PMC12020 Rajagopalan, A., Sathananthan, D., An, Y. K., Van De Ven, L., Martin, S., Fon, J., . . . Bryant, R. V. (2020). Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. JGH Open, 4(2), 267-272.
Scopus5 Europe PMC12020 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. V. (2020). Point-of-care gastrointestinal ultrasound in inflammatory bowel disease: An accurate alternative for disease monitoring. JGH Open, 4(2), 273-279.
Scopus32020 Costello, S. P., & Bryant, R. V. (2020). Editorial: faecal microbiota transplantation—the silver bullet for severe and fulminant Clostridioides difficile infection?. Alimentary Pharmacology and Therapeutics, 51(1), 180-181.
2020 Soo, W. T., Bryant, R. V., & Costello, S. P. (2020). Faecal microbiota transplantation: Indications, evidence and safety. Australian Prescriber, 43(2), 36-38.
2020 Flanagan, E., Wright, E. K., Begun, J., Bryant, R. V., An, Y. K., Ross, A. L., . . . Bell, S. J. (2020). Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography. Journal of Crohn's and Colitis, 14(10), 1405-1412.
Scopus3 WoS22020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). COVID-19 and implications for thiopurine use. Medical Journal of Australia, 212(10), 490-490.e1.
Scopus1 WoS12020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). ABC of topical therapy in inflammatory bowel disease. JGH Open, 4(4), 556-557.
2019 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600.
Scopus11 WoS8 Europe PMC42019 Oakland, K., Kahan, B., Guizzetti, L., Martel, M., Bryant, R., Brahmania, M., . . . Jairath, V. (2019). Development, Validation, and Comparative Assessment of an International Scoring System to Determine Risk of Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology, 17(6), 1121.
Scopus9 WoS10 Europe PMC42019 Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63.
2019 Costello, S., Hughes, P., Waters, O., Bryant, R., Vincent, A., Blatchford, P., . . . Andrews, J. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164.
Scopus167 WoS162 Europe PMC222019 Costello, S. P., & Bryant, R. V. (2019). Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal Medicine Journal, 49(2), 148-151.
Scopus6 WoS5 Europe PMC52019 Wardill, H., Secombe, K., Bryant, R., Hazenberg, M., & Costello, S. (2019). Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine, 44, 730-740.
Scopus18 WoS14 Europe PMC112019 Bryant, R. V., & Costello, S. P. (2019). Editorial: assessing histological disease activity in Crohn’s disease—a call for standardisation of mucosal biopsy location. Alimentary Pharmacology and Therapeutics, 50(1), 103-104.
Scopus2 WoS2 Europe PMC12019 Biswas, S., Bryant, R. V., & Travis, S. (2019). Interfering with leukocyte trafficking in Crohn's disease. Best Practice and Research: Clinical Gastroenterology, 38-39, 8 pages.
Scopus10 WoS8 Europe PMC12019 Roberts-Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019). Uncovering the cause of ulcerative colitis. JGH Open, 3(4), 274-276.
Scopus4 Europe PMC22018 Schwerd, T., Bryant, R., Pandey, S., Capitani, M., Meran, L., Cazier, J. -B., . . . Uhlig, H. (2018). NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.. Mucosal immunology, 11(2), 562-574.
Scopus35 WoS29 Europe PMC202018 Bryant, R. V., Friedman, A. B., Wright, E. K., Taylor, K. M., Begun, J., Maconi, G., . . . Gibson, P. R. (2018). Gastrointestinal ultrasound in inflammatory bowel disease: An underused resource with potential paradigm-changing application. Gut, 67(5), 973-985.
Scopus41 WoS35 Europe PMC82018 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607.
Scopus16 WoS14 Europe PMC82018 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17.
Scopus21 WoS20 Europe PMC92017 Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632.
2017 Bryant, R., Prowse, S., Nguyen-Hoang, A., & Lewis, M. (2017). Gastrointestinal: Adenocarcinoma in ileal Crohn's disease: A devil in disguise. Journal of Gastroenterology and Hepatology (Australia), 32(9), 1535.
2017 Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., . . . Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 46(11-12), 1037-1053.
Scopus124 WoS117 Europe PMC562017 Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., MacOni, G., . . . Dietrich, C. (2017). How to perform gastrointestinal ultrasound: Anatomy and normal findings. World Journal of Gastroenterology, 23(38), 6931-6941.
Scopus21 WoS21 Europe PMC102017 Bezzio, C., Bryant, R. V., Manes, G., Maconi, G., & Saibeni, S. (2017). New horizons in the imaging of perianal Crohn’s disease: transperineal ultrasonography. Expert Review of Gastroenterology and Hepatology, 11(6), 523-530.
Scopus4 WoS2 Europe PMC32017 Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224.
Scopus103 WoS101 Europe PMC662017 Guirgis, M., Wendt, E., Wang, L. M., Walsh, A., Burger, D., Bryant, R. V., . . . Keshav, S. (2017). Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis. Journal of Crohn's and Colitis, 11(4), jjw174.
Scopus8 Europe PMC32016 Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., Maconi, G., . . . Dietrich, C. (2016). WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice. Ultrasound in Medicine and Biology, 42(12), 2732-2742.
Scopus27 WoS24 Europe PMC122016 Bryant, R. V., Burger, D. C., Delo, J., Walsh, A. J., Thomas, S., Von Herbay, A., . . . Travis, S. P. L. (2016). Beyond endoscopic mucosal healing in UC: Histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut, 65(3), 408-414.
Scopus157 Europe PMC912016 Bennett, A., Moore, D., Bampton, P., Bryant, R., & Andrews, J. (2016). Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World Journal of Gastroenterology, 22(8), 2611-2620.
Scopus21 WoS22 Europe PMC122016 Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513.
Scopus13 WoS12 Europe PMC82016 Walsh, A., Bryant, R., & Travis, S. (2016). Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology and Hepatology, 13(10), 567-579.
Scopus78 WoS73 Europe PMC462016 Griffiths, E., McDonald, C., Bryant, R., Devitt, P., Bright, T., Holloway, R., & Thompson, S. (2016). Retrospective analysis of surgery and trans-arterial embolization for major non-variceal upper gastrointestinal bleeding. ANZ Journal of Surgery, 86(5), 381-385.
Scopus8 WoS6 Europe PMC52015 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2015). Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 41(9), 895-906.
Scopus63 WoS60 Europe PMC332015 Bryant, R. V., & Andrews, J. M. (2015). Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply. Alimentary Pharmacology and Therapeutics, 41(12), 1304-1305.
Scopus1 WoS1 Europe PMC12015 Bryant, R., Costello, S., & Andrews, J. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328.
Scopus1 WoS1 Europe PMC12015 Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., . . . Colombel, J. F. (2015). Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology, 110(9), 1324-1338.
Scopus765 Europe PMC4212015 Bryant, R. V., Brain, O., & Travis, S. P. L. (2015). Conventional drug therapy for inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 50(1), 90-112.
Scopus41 Europe PMC232015 Bryant, R. V., Sandborn, W. J., & Travis, S. P. L. (2015). Introducing vedolizumab to clinical practice: Who, when, and how?. Journal of Crohn's and Colitis, 9(4), 356-366.
Scopus39 Europe PMC292015 Bryant, R. V., Winer, S., Travis, S. P. L., & Riddell, R. H. (2015). Response to Villanacci et. al. Journal of Crohn's & colitis, 9(5), 429.
2014 Bryant, R. V., Winer, S., SPL, T., & Riddell, R. H. (2014). Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn's and Colitis, 8(12), 1582-1597.
Scopus137 Europe PMC912014 Bryant, R., Jairath, V., Curry, N., & Travis, S. (2014). Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?. Journal of Crohn's and Colitis, 8(2), 166-171.
Scopus17 Europe PMC102013 Bryant, R., Trott, M., Bartholomeusz, F., & Andrews, J. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213-225.
Scopus80 WoS78 Europe PMC532013 Bryant, R., Trott, M., Bennett, A., Bampton, P., Moore, D., & Andrews, J. (2013). Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Internal Medicine Journal, 43(11), 1171-1176.
Scopus4 WoS3 Europe PMC32013 Bryant, R., Kuo, P., Williamson, K., Yam, C., Schoeman, M., Holloway, R., & Nguyen, Q. (2013). Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastrointestinal Endoscopy, 78(4), 576-583.
Scopus68 WoS60 Europe PMC412013 Bryant, R., Schoeman, S., & Schoeman, M. (2013). Shorter preparation to procedure interval for colonoscopy improves quality of bowel cleansing. Internal Medicine Journal, 43(2), 162-168.
Scopus16 WoS15 Europe PMC122012 Bryant, R., Holloway, R., & Nguyen, N. (2012). Gastrointestinal: role of endoscopic ultrasound in the evaluation of pseudoachalasia. Journal of Gastroenterology and Hepatology, 27(6), 1128.
Scopus6 WoS5 Europe PMC12011 Bryant, R., Schoeman, S., & Schoeman, M. (2011). Split vs single day preparation and colonoscopy outcomes in a large single Australian centre. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, 75. 2011 Bryant, R., Van Langenberg, D., Holtmann, G., & Andrews, J. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26(5), 916-923.
Scopus55 WoS52 Europe PMC432010 Andrews, J., Bryant, R., Van Langenberg, D., & Holtmann, G. (2010). Are all symptoms in patients in IBD due to occult inflammation. American Journal of Gastroenterology, 105(12), 2703.
Scopus3 WoS2 -
Conference Items
Year Citation 2018 Rajagopalan, A., Sathananthan, D., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Acceptability, tolerability, and impact on illness-related knowledge. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Fon, J., Costello, S., & Bryant, R. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Accuracy compared with colonoscopy and fecal calprotectin. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2016 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Lau, S., Schoeman, M., . . . Andrews, J. (2016). Treat to target' in ulcerative colitis (UC) in the Australian setting: current practice and potential barriers? A multi-site cross-sectional evaluation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2016 Bryant, R., Costello, S., Tee, D., Schoeman, S., Mountifield, R., & Andrews, J. (2016). Australian gastroenterologists' perceptions of 'treat to target' recommendations for ulcerative colitis: a survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2015 Pilichiewicz, A., Goess, C., Linedale, E., Ooi, S., Bryant, R., Grafton, R., . . . Andrews, J. (2015). Nutrient intake in patients with inflammatory bowel disease: Are they meeting their dietary requirements?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2014 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2014). SARCOPAENIA MEASURED BY DXA IS COMMON IN IBD PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2014 Lim, A., Ooi, S., Bryant, R., Schultz, C., Goess, C., Grafton, R., . . . Andrews, J. (2014). The effects of vitamin D deficiency in patients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Broadbeach, Qld.: Wiley.
2012 Nguyen, N. Q., Bryant, R. V., Kuo, P., Williamson, K. D., Schoeman, M., & Holloway, R. H. (2012). Risk Stratification With Glasgow-Blatchford Bleeding Score for Hospitalized Patients With Upper Gastrointestinal Bleeding Can Avoid the Needs for Urgent Endo-Therapy. Poster session presented at the meeting of GASTROINTESTINAL ENDOSCOPY. San Diego, CA: MOSBY-ELSEVIER.
WoS22012 Rahman, A. H. A., Hrycek, C., Bryant, R. V., Andrews, J., Nguyen, N., Schoeman, M., & Holloway, R. (2012). Is there a 'weekend effect' among patients referred to a dedicated 'haematemesis and melaena' service?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Adelaide, SA: Wiley.
-
Expand
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2021 Co-Supervisor Faecal Microbiota Transplant (FMT) as a safe and efficacious therapeutic alternative for refractory proctitis Master of Philosophy (Medical Science) Master Full Time Dr Sreecanth Raja 2020 Co-Supervisor Development of a gastrointestinal ultrasound idex for inflammatory bowel disease activity Master of Philosophy (Medical Science) Master Full Time Dr Tom Goodsall 2020 Co-Supervisor Rates of resistance and temporal changes to the susceptibility of helicobacter pylori to amoxicillin, clarithromycin, metronidazole and tetracycline in Australia. Master of Philosophy (Medical Science) Master Full Time Mr Jonathon Paul Schubert 2018 Co-Supervisor Diet in Inflammatory Bowel Disease - What's Being Eaten and Can a Defined Strategy Help? Doctor of Philosophy Doctorate Full Time Mrs Alice Sarah Day -
Other Supervision Activities
Date Role Research Topic Location Program Supervision Type Student Load Student Name 2018 - ongoing Principal Supervisor Dietetic Flinders University — Honours — Rachel Davis 2018 - ongoing Principal Supervisor Gastroenterology Advanced Training Research Project University of Adelaide — Other — Dr Arvind Rajagopalan
-
Expand
-
Committee Memberships
Date Role Committee Institution Country 2017 - ongoing Member Australiasian Society for Parenteral and Enteral Nutrition (AUSPEN) Australiasian Society for Parenteral and Enteral Nutrition (AUSPEN) Australia 2016 - ongoing Member GENIUS Gastrointestinal Ultrasound Inaugural GENIUS Gastrointestinal Ultrasound Inaugural Australia 2014 - ongoing Member Conjoint Committee Recognition of Training Gastrointestinal Endoscopy, Upper Endoscopy and Colonoscopy, Gastroenterological Society of Australia (GESA) Gastroenterological Society of Australia (GESA) Australia -
Memberships
Date Role Membership Country 2015 - ongoing Member Crohn’s Colitis Foundation Australia 2014 - ongoing Member British Society of Immunology United Kingdom 2013 - ongoing Member European Crohn’s and Colitis Organisation Denmark 2013 - ongoing Member British Society of Gastroenterology Ukraine 2012 - ongoing Member American Gastroenterology Association United States 2011 - ongoing Member Gastroenterological Society of Australia Australia 2010 - ongoing Member Royal Australasian College of Physicians Australia 2008 - 2012 Member Royal Adelaide Hospital Resident Medical Officers Association Australia
Connect With Me
External Profiles
